Craneware plc, together with its subsidiaries, develops, licenses, and supports computer software for the healthcare industry in the United States. The company provides solutions, such as Trisus pricing transparency software; Trisus Pricing Analyzer, a solution that simplifies and automates the price modeling process; Trisus Chargemaster, an automated chargemaster management solution; InSight Medical Necessity, a solution that offers medical necessity for the United States payors; Trisus Claims Informatics, a retrospective charge capture analytical application that identifies areas of risk for its team to investigate; Trisus Supply, a solution that improves supplies reimbursement; and InSight Audit, an audit management solution for government and commercial payors. It also offers Trisus Decision Support; Trisus Labor Productivity; Trisus Medication Analytic solutions; and Trisus supplies assistant solutions. In addition, the company provides Sentinel, a drug tracking solution; Sentrex, a SaaS-based solution that helps covered entities expand medication access; Referral Verification System; and Central Pharmacy Distribution, a centralized purchasing application. Further, it offers appeal, professional, and pharmacy professional services. Craneware plc was incorporated in 1999 and is headquartered in Edinburgh, the United Kingdom.
Stock data | 2023 | Change |
---|---|---|
Price | $29.30 | N/A |
Market Cap | $1.03B | N/A |
Shares Outstanding | 35.15M | 0.10% |
Employees | 734.00 | N/A |
Shareholder Equity | 327.84M | -1.56% |
Valuation | 2023 | Change |
---|---|---|
P/S Ratio | 5.92 | N/A |
P/B Ratio | 3.14 | N/A |
Growth | 2023 | Change |
---|---|---|
Return on Equity | 0.0282 | N/A |
Earnings | 2023 | Change |
---|---|---|
Revenue | $174.02M | N/A |
Earnings | $9.23M | N/A |
Gross Margin | 0.853 | N/A |
Operating Margin | 0.0986 | N/A |
Net income margin | 0.0531 | N/A |
Financial Strength | 2023 | Change |
---|---|---|
Total Assets | $576.98M | N/A |
Total Debt | $86.69M | N/A |
Cash on Hand | $78.54M | N/A |
Debt to Equity | 0.7599 | 8.64% |
Cash to Debt | 0.9060 | 121.94% |
Current Ratio | 0.8947 | -20.61% |